Home Cart Sign in  
Chemical Structure| 1510829-06-7 Chemical Structure| 1510829-06-7

Structure of Vecabrutinib
CAS No.: 1510829-06-7

Chemical Structure| 1510829-06-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Vecabrutinib is a potent BTK inhibitor, with IC50s of 4.6 nM and 1.1 nM for WT BTK and C481S BTK, respectively, and also inhibits ITK activity (IC50, 24 nM).

Synonyms: SNS-062

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vecabrutinib

CAS No. :1510829-06-7
Formula : C22H24ClF4N7O2
M.W : 529.92
SMILES Code : O=C([C@@H]1[C@@H](N2C([C@H](NC3=CC(C(F)(F)F)=CC(Cl)=C3)CCC2)=O)CN(C4=NC=NC(N)=C4F)CC1)N
Synonyms :
SNS-062
MDL No. :MFCD31692359
InChI Key :QLRRJMOBVVGXEJ-XHSDSOJGSA-N
Pubchem ID :72547837

Safety of Vecabrutinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Vecabrutinib

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03037645 Chronic Lymphocytic Leukemia|S... More >>mall Lymphocytic Lymphoma|Lymphoplasmacytoid Lymphoma|Mantle-Cell Lymphoma|Waldenstrom Macroglobulinemia|Diffuse Large B Cell Lymphoma|Follicular Lymphoma|Marginal Zone Lymphoma Less << PHASE1|PHASE2 TERMINATED 2020-08-31 University of California Irvin... More >>e Medical Center, Orange, California, 92868-3201, United States|UC San Diego Moores Cancer Center, San Diego, California, 92093, United States|Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, 21231, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Weill Cornell Medicine, New York, New York, 10065, United States|Willamette Valley Cancer Institute and Research Center, Eugene, Oregon, 97401, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Texas Oncology - Tyler, Tyler, Texas, 75702, United States|Swedish Cancer Institute, Seattle, Washington, 98104, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.89mL

0.38mL

0.19mL

9.44mL

1.89mL

0.94mL

18.87mL

3.77mL

1.89mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories